Danaher Life Sciences — Sales increased by 16.4% to $2.09B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $2.03B to $2.09B. Over 2 years (FY 2023 to FY 2025), Life Sciences — Sales shows relatively stable performance with a 1.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growing market share or demand for life science products, while a decrease may signal market saturation or competitive pressure.
Represents the total revenue generated from the sale of goods and services within the Life Sciences business segment. Th...
Comparable to segment-level revenue reported by peers in the life sciences and diagnostics tools industry.
dhr_segment_life_sciences_sales| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.73B | $3.63B | $3.88B | $3.97B | $3.78B | $1.71B | $1.80B | $1.71B | $1.93B | $1.75B | $1.77B | $1.78B | $2.03B | $1.68B | $1.78B | $1.79B | $2.09B |
| QoQ Change | — | -2.7% | +6.9% | +2.2% | -4.8% | -54.7% | +5.1% | -5.0% | +13.1% | -9.6% | +1.4% | +0.7% | +14.0% | -17.3% | +5.8% | +0.8% | +16.4% |
| YoY Change | — | — | — | +6.2% | +4.0% | -56.0% | -54.7% | -54.8% | — | +2.1% | -1.4% | +4.5% | +5.3% | -3.7% | +0.4% | +0.6% | +2.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.